Published in:
01-08-2020 | COVID-19 | IMAGES THAT TEACH
Lurking in the shadows: Asymptomatic bilateral lung involvement with novel corona virus 2019 identified on myocardial perfusion SPECT CT: Implications for interpreting physicians
Authors:
Karthik Ananthasubramaniam, MD, FACC, FASE, FASNC, FSCCT, FRCP, Vanji Karthikeyan, MD
Published in:
Journal of Nuclear Cardiology
|
Issue 4/2020
Login to get access
Excerpt
A 47-year-old African American male with end-stage kidney disease (ESKD) on home hemodialysis (HD), diabetes, hypertension, and type 2 pulmonary hypertension with preserved ejection fraction was referred for preoperative risk assessment to be listed for kidney transplant. He was evaluated by a video visit given the ongoing coronavirus disease 2019 (COVID-19) viral pandemic by his primary care physician late March 2020 and in 1st week of April 2020 by a cardiologist. Review of primary care physician and cardiologist notes highlighted patient had no general or cardiac symptoms, was compliant with his medications and performed his dialysis sessions regularly at home. His medications included low dose aspirin, atorvastatin, metoprolol, and insulin. He was felt to need further risk assessment and subsequently underwent a same day rest-regadenoson stress Technetium sestamibi SPECT/attenuation correction CT study for preoperative risk assessment on April 8th, 2020. …